Skip to main content
Fig. 4 | BMC Neuroscience

Fig. 4

From: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies

Fig. 4

Analysis of NeuN cell counts in 3R tau transgenic mice treated with CBL. a Immunocytochemistry with an antibody against NeuN in the 3–6 month group. b Stereological analysis with the dissector method to estimate the numbers of NeuN positive cells in the neocortex and hippocampus in the 3–6 month group. c Immunocytochemistry with an antibody against NeuN in the brains of the 6–9 month group. d Stereological analysis with the dissector method to estimate the numbers of NeuN positive cells in the neocortex and hippocampus in the 6–9 month group. For analysis, N = 10 non-tg and N = 10 3R Tau tg mice from each age and treatment group. *P < 0.05 when compared to non-tg control using one way ANOVA with Dunnet’s post hoc test. # P < 0.05 when compared to vehicle-treated tg mice control using one way ANOVA with Dunnet’s post hoc test

Back to article page